Table 1.
Comparison of basal parameters between different groups
| Basal parameters | HA+ | HA− | Control |
|---|---|---|---|
| N | 62 | 69 | 61 |
| Age (year) | 29.95 ± 4.13 | 29.22 ± 4.07 | 30.31 ± 3.83 |
| BMI (kg/m2) | 20.1 ± 5.76ab | 23.35 ± 5.22c | 20.52 ± 1.58 |
| AMH (ng/ml) | 8.41 ± 4.57ab | 5.81 ± 3.85c | 3.74 ± 2.25 |
| FSH (IU/L) | 5.42 ± 1.68 | 5.17 ± 1.40 | 5.72 ± 1.52 |
| LH (IU/L) | 18.21 ± 5.46ab | 7.9 ± 34.00c | 4.20 ± 2.02 |
| E2 (ng/mL) | 50.30 ± 27.6ab | 41.28 ± 17.07 | 35.80 ± 12.83 |
| T (nmol/L) | 0.93 ± 0.30ab | 0.55 ± 0.22 | 0.51 ± 0.21 |
| PRL (μg/L) | 21.50 ± 12.58 | 18.85 ± 9.32 | 18.73 ± 10.72 |
| Fasting glucose (mmol/L) | 4.80 ± 0.37 | 5.11 ± 1.23c | 4.49 ± 0.59 |
| Fasting insulin (IU/mL) | 9.38 ± 4.38a | 12.17 ± 6.78 | 10.53 ± 4.83 |
| HOMA-IR | 2.02 ± 0.95a | 2.87 ± 2.04c | 2.11 ± 1.08 |
| TG (mmol/L) | 1.00 ± 0.57 | 1.26 ± 0.79 | 1.07 ± 0.71 |
| HDL (mmol/L) | 1.59 ± 0.37 | 1.47 ± 0.36 | 1.52 ± 0.21 |
| LDL (mmol/L) | 2.81 ± 0.59 | 3.11 ± 0.93 | 3.05 ± 0.61 |
| TC (mmol/L) | 4.63 ± 0.53 | 4.89 ± 0.96 | 4.73 ± 0.64 |
| APO-A (g/L) | 1.60 ± 0.30 | 1.54 ± 0.32 | 1.66 ± 0.27 |
| APO-B (g/L) | 0.72 ± 0.17 | 0.80 ± 0.19 | 0.78 ± 0.17 |
HA+: PCOS patient with hyperandrogenism, HA−: PCOS patient without hyperandrogenism
aP < 0.05, when the HA+ group was compared with the HA− group
bP < 0.05, when the HA+ group was compared with the control group
cP < 0.05, when the HA− group was compared with the control group